Description
The aim of UHC is to provide more and better-quality services to a greater proportion of the population, while also increasing the level of financial protection. This webinar looks at another function of the health care financing system related to service provision, and present a tool developed by WHO for cancer planning and control. In particular, it illustrates how we can use tools to help formulate and cost a cancer control plan, how can these tools be used to inform health system planning and how can we use these approaches to set priorities as part of UHC health benefit packaging design.
Click on the Resources tab above to access WHO's resources related to this presentation.
Contributors
-
Dr Filip Meheus
Dr. Filip Meheus is a Health Economist in the Department of Financing and Economics at the World Health Organisation.
-
Dr André Ilbawi
Dr Ilbawi joined the WHO Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention (NVI) in August 2015 as a Technical Officer. His work supports the priority actions identified at the April 2015 First Strategic and Technical Meeting on the Management of Cancer, aligned with the WHO Global action plan for the prevention and control of noncommunicable diseases 2013-2020. His current projects include a policy statement on cancer screening and a technical document on comprehensive oral cancer control.
Alongside a broad alliance of WHO departments, he is also supporting the development of a workplan on childhood cancers and related products as well as programmes aimed at improving health systems including access to essential surgical services, particularly as they relate to cancer care. Dr André Ilbawi is a native of the United States. He graduated with an undergraduate degree in bioengineering and received his M.D. from the University of Pennsylvania. Prior to commencing work at WHO, he was trained as a cancer surgeon at the University of Washington and MD Anderson Cancer Centre. He was involved in clinical and research efforts focusing on cancer care in low-resource settings, health system development, and strengthening cost-effective surgical services, including serving as a commissioner in the Lancet Oncology Commission on Global Cancer Surgery.